HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer

Abstract : Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor that inhibits plasmin-dependent activation of several metalloproteinases. Downregulation of TFPI-2 could thus enhance the invasive potential of neoplastic cells in several cancers, including lung cancer. In this study, TFPI-2 mRNA was measured using a real-time PCR method in tumours of 59 patients with non-small-cell lung cancer (NSCLC). Tumour TFPI-2 mRNA levels appeared well correlated with protein expression evaluated by immunohistochemistry and were 4-120 times lower compared to those of nonaffected lung tissue in 22 cases (37%). Hypermethylation of the TFPI-2 gene promoter was demonstrated by restriction enzyme-polymerase chain reaction in 12 of 40 cases of NSCLC (30%), including nine of 17 for whom tumour TFPI-2 gene expression was lower than in noncancerous tissue. In contrast, this epigenetic modification was shown in only three of 23 tumours in which no decrease in TFPI-2 synthesis was found (P ¼ 0.016). Decreased TFPI-2 gene expression and hypermethylation were more frequently associated with stages III or IV NSCLC (eight out of 10, P ¼ 0.02) and the TFPI-2 gene promoter was more frequently hypermethylated in patients with lymph node metastases (eight out of 16, P ¼ 0.02). These results suggest that silencing of the TFPI-2 gene by hypermethylation might contribute to tumour progression in NSCLC.
Complete list of metadata

Cited literature [35 references]  Display  Hide  Download

Contributor : Florent Hube Connect in order to contact the contributor
Submitted on : Monday, May 13, 2019 - 1:47:37 PM
Last modification on : Tuesday, March 15, 2022 - 3:52:02 PM


10-2005-Brit J Cancer.pdf
Publisher files allowed on an open archive



J. Rollin, S Iochmann, C Bléchet, F Hubé, S. Regina, et al.. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. British Journal of Cancer, Cancer Research UK, 2005, 92 (4), pp.775-783. ⟨10.1038/sj.bjc.6602298⟩. ⟨hal-02127361⟩



Record views


Files downloads